Clin. Otolaryngol. 2012, 37, 44–52 Background:  Although relatively uncommon, penetrating neck trauma has the potential for serious morbidity and an estimated mortality of up to 6%. The assessment and management of patients who have sustained a penetrating neck injury has historically been an issue surrounded by significant controversy. Objectivesof review:  To assess recent evidence relating to the assessment and management of penetrating neck trauma, highlighting areas of controversy with an overall aim of formulating clinical guidelines according to a care pathway format. Type of review:  Structured, non‐systematic review of recent medical literature. Search strategy:  An electronic literature search was performed in May 2011. The Medline database was searched using the Medical Subject Headings terms ‘neck injuries’ and ‘wounds, penetrating’ in conjunction with the terms ‘assessment’ or ‘management’. Embase was searched with the terms ‘penetrating trauma’ and ‘neck injury’, also in conjunction with the terms ‘assessment’ and ‘management’. Results were limited to articles published in English from 1990 to the present day. Evaluation method:  Abstracts were reviewed by the first three authors to select full‐text articles for further critical appraisal. The references and citation links of these articles were hand‐searched to identify further articles of relevance. Results:  147 relevant articles were identified by the electronic literature search, comprising case series, case reports and reviews. 33 were initially selected for further evaluation. Conclusions:  Although controversy continues to surround the management of penetrating neck trauma, the role of selective non‐operative management and the utility of CT angiography to investigate potential vascular injuries appears to be increasingly accepted.

ObjectiveIBD prevalence is estimated to be rising, but no detailed, recent UK data are available. The last reported prevalence estimate in the UK was 0.40% in 2003. We aimed to establish the current, and project future, prevalence in Lothian, Scotland.DesignWe conducted an all-age multiparameter search strategy using inpatient IBD international classification of disease (ICD-10) coding (K50/51)(1997–2018), IBD pathology coding (1990–2018), primary and secondary care prescribing data (2009–2018) and a paediatric registry, (1997–2018) to identify ‘possible’ IBD cases up to 31/08/2018. Diagnoses were manually confirmed through electronic health record review as per Lennard-Jones/Porto criteria. Autoregressive integrated moving average (ARIMA) regression was applied to forecast prevalence to 01/08/2028.ResultsIn total, 24 601 possible IBD cases were identified of which 10 499 were true positives. The point prevalence for IBD in Lothian on 31/08/2018 was 784/100 000 (UC 432/100 000, Crohn’s disease 284/100 000 and IBD unclassified (IBDU) 68/100 000). Capture–recapture methods identified an additional 427 ‘missed’ cases (95% CI 383 to 477) resulting in a ‘true’ prevalence of 832/100 000 (95% CI 827 to 837).Prevalence increased by 4.3% per year between 2008 and 2018 (95% CI +3.7 to +4.9%, p<0.0001). ARIMA modelling projected a point prevalence on 01/08/2028 of 1.02% (95% CI 0.97% to 1.07%) that will affect an estimated 1.53% (95% CI 1.37% to 1.69%) of those >80 years of age.ConclusionsWe report a rigorously validated IBD cohort with all-age point prevalence on 31/08/2018 of 1 in 125, one of the highest worldwide.

No abstract